1. Home
  2. BNR vs CIK Comparison

BNR vs CIK Comparison

Compare BNR & CIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

N/A

Current Price

$13.00

Market Cap

141.5M

Sector

Health Care

ML Signal

N/A

Logo Credit Suisse Asset Management Income Fund Inc.

CIK

Credit Suisse Asset Management Income Fund Inc.

N/A

Current Price

$2.36

Market Cap

127.8M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
BNR
CIK
Founded
2014
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Medical Specialities
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
141.5M
127.8M
IPO Year
2019
1995

Fundamental Metrics

Financial Performance
Metric
BNR
CIK
Price
$13.00
$2.36
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
23.4K
★ 411.9K
Earning Date
11-23-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$101.46
N/A
Revenue Next Year
$14.81
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.79
$2.26
52 Week High
$41.72
$2.88

Technical Indicators

Market Signals
Indicator
BNR
CIK
Relative Strength Index (RSI) 51.21 53.54
Support Level $9.12 $2.26
Resistance Level $19.10 $2.40
Average True Range (ATR) 1.26 0.03
MACD 0.16 0.01
Stochastic Oscillator 88.67 65.38

Price Performance

Historical Comparison
BNR
CIK

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

About CIK Credit Suisse Asset Management Income Fund Inc.

Credit Suisse Asset Mgmt Income Fund Inc is a closed-end management investment company. The investment objective of the fund is to provide current income consistent with the preservation of capital. UBS Asset Management serves as an investment adviser for the fund. Asset Management offers a wide range of investment products and functions across asset classes and investment styles. The division manages various regional portfolios, mutual funds, and other investment vehicles for governments, institutions, corporations and individuals.

Share on Social Networks: